110 related articles for article (PubMed ID: 12078899)
1. Genetic susceptibility to Hodgkin's lymphoma and to secondary cancer: workshop report.
Staratschek-Jox A; Shugart YY; Strom SS; Nagler A; Taylor GM
Ann Oncol; 2002; 13 Suppl 1():30-3. PubMed ID: 12078899
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region.
Diepstra A; Niens M; te Meerman GJ; Poppema S; van den Berg A
Eur J Haematol Suppl; 2005 Jul; (66):34-41. PubMed ID: 16007866
[TBL] [Abstract][Full Text] [Related]
3. Familial Hodgkin's lymphoma from the perspective of HLA.
Sonmez M; Erkut N; Ucar F; Buruk K; Cobanoglu U; Bahce M; Ural AU
Intern Med; 2010; 49(6):607-10. PubMed ID: 20228601
[TBL] [Abstract][Full Text] [Related]
4. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
6. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden.
Shugart YY; Hemminki K; Vaittinen P; Kingman A; Dong C
Hum Genet; 2000 May; 106(5):553-6. PubMed ID: 10914686
[TBL] [Abstract][Full Text] [Related]
7. Familial Hodgkin's disease and associated cancer. A clinical-pathologic study.
Lynch HT; Saldivar VA; Guirgis HA; Terasaki PI; Bardawil WA; Harris RE; Lynch JF; Thomas R
Cancer; 1976 Nov; 38(5):2033-41. PubMed ID: 991117
[TBL] [Abstract][Full Text] [Related]
8. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
9. Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.
Alexandrescu DT; Garino A; Brown-Balem KA; Wiernik PH
Leuk Lymphoma; 2006 Oct; 47(10):2115-27. PubMed ID: 17071485
[TBL] [Abstract][Full Text] [Related]
10. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
11. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease.
Strom SS; Gu Y; Sigurdson AJ; Bailey NM; Amos CI; Spitz MR; Rodriguez MA; Liang JC
Leuk Lymphoma; 1998 Feb; 28(5-6):561-6. PubMed ID: 9613986
[TBL] [Abstract][Full Text] [Related]
12. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.
Besson C; Roetynck S; Williams F; Orsi L; Amiel C; Lependeven C; Antoni G; Hermine O; Brice P; Ferme C; Carde P; Canioni D; Brière J; Raphael M; Nicolas JC; Clavel J; Middleton D; Vivier E; Abel L
PLoS One; 2007 May; 2(5):e406. PubMed ID: 17476328
[TBL] [Abstract][Full Text] [Related]
13. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.
Uçar F; Sönmez M; Ermantaş N; Özbaş HM; Cansız A; Balcı M; Yılmazz M
Gene; 2016 Jul; 586(2):263-7. PubMed ID: 27063556
[TBL] [Abstract][Full Text] [Related]
14. HLA Polymorphism in Algerian Children With Lymphomas.
Galleze A; Raache R; Amroun H; Cherif N; Fadli M; Meçabih F; Mecheti B; Belhani M; Bensenouci A; Abbadi MC; Attal N
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e458-61. PubMed ID: 26334430
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HL-A antigens in patients with Hodgkin's disease and their families.
Forbes JF; Morris PJ
J Clin Invest; 1972 May; 51(5):1156-63. PubMed ID: 5020429
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications.
Kelly KM; Perentesis JP;
Ann Oncol; 2002; 13 Suppl 1():34-9. PubMed ID: 12078900
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma.
Jarrett RF
Leuk Lymphoma; 2003; 44 Suppl 3():S27-32. PubMed ID: 15202522
[TBL] [Abstract][Full Text] [Related]
18. Familial Hodgkin's lymphoma in Scandinavia.
Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE
In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419
[TBL] [Abstract][Full Text] [Related]
19. Can Burkitt's Lymphoma and Hodgkin's Lymphoma occur in siblings simultaneously?
Kaymak Cihan M; Kandemir O; Dalva K; Sarı N; Kurucu N; Ergürhan İlhan İ
Turk J Pediatr; 2015; 57(5):536-40. PubMed ID: 27411427
[TBL] [Abstract][Full Text] [Related]
20. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
